IQVIA Holdings Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for IQV, updated each market day.
IQV AI Sentiment
AI sees no strong directional signal for IQVIA Holdings Inc. stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Sector
Exchange
Market Cap
$44,349,824,000
Cap Tier
Employees
94,000
Headquarters
DURHAM, NC
Listed Since
May 9, 2013
Website
IQV Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IQV Volatility
IQVIA Holdings Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
